SCENARIA View Phase

by FUJIFILM Corporation  · Based in Japan → — The next level in CT is here, delivering next-generation clinical practice for healthier futures.
Cardiology Oncology Radiology

Contact for pricing
Regulatory Status Disclosed

Overview

FUJIFILM SCENARIA View Phase is a high-performance multi-slice CT system designed to meet diverse diagnostic needs across the entire body, including the head, heart, and abdomen. Leveraging Fujifilm’s extensive experience and advanced AI technology, it aims to provide more accurate, less invasive, and more efficient examinations. The system integrates AI-based iterative reconstruction (Intelli IPV) to significantly reduce radiation dose while maintaining superb image quality. It also features AI-powered workflow solutions such as AutoPose for automated patient positioning and SYNAPSE 3D integration for advanced image analysis, including automatic organ segmentation. SCENARIA View is built with patient comfort in mind, offering a wide 80cm gantry aperture, a high-capacity patient table, and motion correction capabilities for challenging exams like cardiac imaging.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-based iterative reconstruction (Intelli IPV) for up to 83% dose reduction and high image quality
  • Cardio StillShot for motion correction in cardiac CT, achieving 28ms effective temporal resolution
  • AutoPose AI function for automatic scan range and dimension setting based on scanogram
  • Wide 80cm gantry aperture and 550lbs (250kg) table weight capacity for patient comfort
  • Auto Lateral Shift Table (u00b110cm) for precise patient positioning and dose reduction
  • DICOM Dose Structured Report and Dose Check (NEMA XR-25 compliant) for dose reporting and awareness
  • HiMAR Plus metal artifact reduction
  • SYNAPSE 3D integration for advanced image analysis and automatic organ segmentation
  • 64-slice acquisition with up to 128-slice reconstruction
  • Fast 0.35-second scan time for reduced breath-holds and motion artifacts

Use Cases

  • Whole-body CT imaging (head, heart, abdomen)
  • Cardiac CTA and motion correction for heart imaging
  • Low-dose CT lung cancer screening
  • Interventional needle guidance
  • Diagnosis of various diseases
  • Advanced 3D visualization and analysis for clinical interpretation and treatment planning

What Physicians Need to Know

ECG/EKG Analysis Capability
SCENARIA View utilizes ECG data for 'CardioHarmony' to automatically select the cardiac phase with the least heart motion for image reconstruction after CT scanning. 'IntelliEC Cardiac' adjusts X-ray radiation dose based on ECG data, reducing exposure during non-target heart phases. 'CardioConductor' captures heart rate ranges during breath-holding and automatically calculates scan parameters and image reconstruction phases based on ECG data.
Cardiac CT/MRI Analysis
The SCENARIA View is a 128-slice CT system with advanced clinical modules for Cardiac CTA. Its 'Cardio StillShot' feature provides advanced cardiac motion correction for the entire heart, including arteries and valves, achieving an effective temporal resolution of 28 milliseconds, significantly improving image quality even with challenging heart rates. 'Intelli IPV', an AI-based iterative reconstruction technology, reduces image noise by up to 90% and radiation exposure by up to 83% while maintaining image texture and improving low contrast detectability. 'HiMAR Plus' offers metal artifact reduction, and 'AutoPose' is an AI-based function that automatically sets scan and reconstruction ranges for various body parts, including the heart.
Arrhythmia Detection Accuracy
While 'Cardio StillShot' is designed to provide precise cardiac imaging even with irregular heart rates by correcting motion, it focuses on image quality for diagnosis rather than explicit arrhythmia detection accuracy.
Heart Failure Risk Prediction
Clear cardiac CT images produced by SCENARIA View can aid clinical teams in diagnosing heart problems such as heart failure. However, the provided information does not explicitly detail an AI feature for heart failure *risk prediction*.
Coronary Artery Assessment
SCENARIA View is well-suited for Coronary Computed Tomography Angiography (CCTA), enabling imaging of the entire coronary arterial tree. 'Cardio StillShot' helps visualize coronary arteries and identify plaque deposits. Submillimeter slices optimize fine detail images for vessel assessment.
Cardiac Monitoring Integration
The system integrates with ECG monitoring for cardiac gating and dose modulation during CT scans.
AHA/ACC Guideline Alignment
No explicit mention of direct alignment with AHA/ACC guidelines was found in the provided information.
Real-Time Alert Capability
SCENARIA View includes 'Dose Check', compliant with NEMA XR-25, to monitor for exam doses that may exceed notice or alert levels. 'Intelli EC Plus' can be set for real-time control of mA, and 'Predict Scan' monitors contrast uptake to automatically initiate scans for optimized image contrast.
Physician Tip

Leverage 'Cardio StillShot' for challenging cardiac cases, especially those with high or irregular heart rates, to achieve high-quality diagnostic images and potentially reduce the need for repeat scans. Utilize the AI-powered dose reduction and image reconstruction technologies like 'Intelli IPV' and 'IntelliEC Cardiac' to minimize patient radiation exposure without compromising diagnostic confidence. Take advantage of streamlined workflow features such as 'AutoPose' and 'CardioHarmony' for efficient and precise cardiac CT examinations.

The SCENARIA View system supports DICOM for dose structured reports and image transfer, facilitating integration into existing PACS and IT infrastructure. Fujifilm's REiLI AI platform provides an open environment for deploying AI algorithms from both Fujifilm and other developers, suggesting potential for broader AI integrations in the future. The 'Cardio StillShot' software integrates with NVIDIA GPUs for enhanced performance.

Details

Category Cardiology AI, Oncology AI, Radiology & Imaging AI
Pricing Contact for pricing — Not publicly available
DeploymentOn-premise
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

The SCENARIA View Phase 5.0 (K250370) received FDA 510(k) clearance on May 20, 2025. It is indicated for acquiring axial volumes of the whole body, including the head, and supports interventional needle guidance and low-dose CT lung cancer screening.

Integrations
EHR Not specified
Specialties Cardiology, Oncology, Radiology

What the Web Says

The Fujifilm SCENARIA View Phase is a 128-slice CT scanner designed to provide high-quality images with reduced radiation dose and enhanced workflow efficiency. It offers advanced features for various applications, including cardiac, interventional, and orthopedic imaging, and is particularly noted for its dose reduction capabilities and motion correction technology for cardiac scans.

Overall: Positive

Strengths

  • Enhanced dose efficiency and reduction capabilities, including lower kV settings and ECG Dose Modulation for cardiac exams.
  • Superb image quality with features like Intelli IPV iterative reconstruction and HiVision Detector for clarity and noise reduction.
  • Cardio StillShot technology provides motion correction for clearer heart images, even with high heart rates, and enables lower radiation doses for cardiac scans.
  • Improved workflow speed and ease of use through automation, such as AutoPose for scan range setting and reduced examination time.
  • Accommodates a larger range of patient types due to a high weight capacity table (up to 550 lbs), wide 80cm gantry aperture, and lateral shift table for proper positioning.
  • Versatile capabilities with advanced clinical modules for interventional CT, perfusion exams, cardiac CTA, and dual energy examinations.

Limitations

  • Specific negative reviews or opinions from physicians, healthcare IT, tech reviewers, Reddit, G2, or Capterra were not found in the search results.
  • The provided information primarily consists of product descriptions and regulatory submissions, which may not fully reflect user experiences in all aspects.

Based on reviews from: accessdata.fda.gov, CMS Imaging, Brown's Medical Imaging, MXR Imaging, Fujifilm Healthcare Solutions, YouTube

Last updated: 2026-07-18

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate SCENARIA View Phase

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

accessdata.fda.gov
SCENARIA View Phase 5.0 510(k) Clearance
FUJIFILM Corporation received 510(k) clearance from the FDA for its SCENARIA View Phase 5.0, a multi-slice CT system, on May 20, 2025. This regulatory announcement details the system's indications for use, including whole-body axial volume acquisition and interventional needle guidance.
2025-05
X-ray Interpreter
SCENARIA View Phase 5.0 - X-ray Interpreter
SCENARIA View Phase 5.0 is a multi-slice CT system from FUJIFILM that incorporates AI-based features like AutoPose for automated scan range setting, enhancing workflow and accuracy. The system supports high-quality imaging with motion correction and advanced post-processing capabilities.
2025-05
FDA.report
System, X-Ray, Tomography, Computed JAK - FDA.report
This report lists SCENARIA View Phase 5.0 by Fujifilm Corporation with a 510(k) clearance date of May 20, 2025, under the product code JAK for Computed Tomography X-Ray Systems.
2025-05
Physician Ai Tools
FUJIFILM SCENARIA View Phase - Physician Ai Tools
FUJIFILM SCENARIA View Phase is highlighted as an AI-powered CT system that offers advanced imaging, significant dose reduction, and streamlined workflows for comprehensive diagnostics.
2026-04
Grand View Research
AI In Radiology Market Size And Share Report, 2026-2033
The Grand View Research report on the AI in Radiology Market mentions FUJIFILM Corporation's SCENARIA View Phase 5.0 with a release date of May 16, 2025, as an AI-enabled device contributing to market growth driven by demand for accurate and early disease detection.
2026-07
accessdata.fda.gov
TPLC - Total Product Life Cycle - accessdata.fda.gov
The FDA's Total Product Life Cycle database shows SCENARIA View Phase 5.0 from FUJIFILM CORPORATION as substantially equivalent, with a reference to its 510(k) clearance (K250370).
2026-07
aidoc.com
CT/CTA radiology AI tools | FDA-cleared directory
SCENARIA View Phase 5.0 by FUJIFILM Corporation is listed in an FDA-cleared directory for CT/CTA radiology AI tools, indicating its capabilities in image analysis and processing.
unknown

Videos

Product demos, reviews, and walkthroughs for SCENARIA View Phase.

View all on YouTube

Frequently Asked Questions

The SCENARIA View Phase incorporates AI-based functions like AutoPose and AutoPositioning to streamline workflow by automatically setting scan and reconstruction ranges and assisting with patient positioning. Additionally, its Intelli IPV iterative reconstruction, developed with AI, significantly reduces radiation dose and image noise while maintaining diagnostic image quality and improving low-contrast detectability.
The SCENARIA View system, including its AI features, is FDA 510(k) cleared, notably for Low-Dose CT lung cancer screening. It also complies with NEMA XR-25 for Dose-Check control and NEMA XR-29 for Smart-Dose compliance, providing DICOM Dose Structured Reports to meet dose record requirements.
While AI features like AutoPose and AutoPositioning assist with initial setup, they require final checking and manual adjustment by the operator to ensure accurate patient positioning and scan range. Furthermore, the performance and accuracy of the system's AI do not automatically change after initial deployment, meaning ongoing updates or calibration may be necessary rather than continuous real-time learning.
The SCENARIA View system transfers volume datasets to external devices via a DICOM standard interface, which is a widely accepted protocol for medical image communication and management. This adherence to DICOM standards helps ensure secure and compliant handling of patient imaging data within existing healthcare IT infrastructures.
Physicians considering alternatives to SCENARIA View Phase might look at other CT systems from manufacturers such as GE Healthcare (e.g., Revolution Apex series), Philips (e.g., Spectral CT), Siemens Healthineers (e.g., Somatom series), and other Fujifilm models like FCT iStream or Supria family. These systems also offer various levels of advanced imaging, dose reduction, and workflow automation technologies.
The price for a SCENARIA View 128 system can range from approximately $138,252 to $518,445, with an average price around $328,349. The integrated AI features contribute to cost-effectiveness by enabling significant dose reduction, improving workflow efficiency through automation, and potentially enhancing diagnostic accuracy, which can lead to better patient outcomes and optimized resource utilization.
While specific training details for AI features are not extensively outlined, Fujifilm generally offers periodic software and application training updates with their systems. Effective utilization of advanced features like Intelli IPV for dose reduction often involves consultation with radiologists and physicists to determine appropriate protocols for diagnostic image quality.

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

More from Fujifilm

ECHELON Synergy
Fujifilm Corporation
Radiology & Imaging AI
ECHELON Synergy is Fujifilm's AI-powered 1.5T MRI system, cleared by the FDA, that utilizes Deep Learning Reconstruction (DLR) to deliver high-quality images, faster scan times, and enhanced patient comfort through features like a wide bore and motion artifact reduction technologies. [2, 7, 18, 22]
EW10-EC02 Endoscopy Support Program
FUJIFILM Corporation
Gastroenterology AI
The FUJIFILM EW10-EC02 Endoscopy Support Program, part of the CAD EYE system, is an AI-powered software that provides real-time visual and auditory alerts to aid endoscopists in detecting colonic polyps and adenomas during colonoscopy procedures.
Synapse 3D Base Tools
FUJIFILM Corporation
Radiology & Imaging AI
FUJIFILM Synapse 3D Base Tools is advanced medical imaging software offering comprehensive 2D, 3D, and 4D visualization, AI-powered segmentation, and image analysis for various modalities to enhance diagnostic workflows and treatment planning.
Synapse Lung Nodule AI
Fujifilm Corporation
Oncology AI
Fujifilm's Synapse Lung Nodule AI is an AI software algorithm for detecting pulmonary nodules on CT imaging, aiming to support early detection and treatment of lung cancer.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-18 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.